MIST
Price
$1.80
Change
+$0.08 (+4.65%)
Updated
Dec 20 closing price
99 days until earnings call
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Dec 20 closing price
87 days until earnings call
Ad is loading...

MIST vs SQZB

Header iconMIST vs SQZB Comparison
Open Charts MIST vs SQZBBanner chart's image
Milestone Pharmaceuticals
Price$1.80
Change+$0.08 (+4.65%)
Volume$287.42K
CapitalizationN/A
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$6.9K
CapitalizationN/A
MIST vs SQZB Comparison Chart
Loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIST vs. SQZB commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIST is a Hold and SQZB is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (MIST: $1.80 vs. SQZB: $0.03)
Brand notoriety: MIST and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIST: 68% vs. SQZB: 47%
Market capitalization -- MIST: $95.19M vs. SQZB: $737.28K
MIST [@Biotechnology] is valued at $95.19M. SQZB’s [@Biotechnology] market capitalization is $737.28K. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIST’s FA Score shows that 0 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • MIST’s FA Score: 0 green, 5 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, both MIST and SQZB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIST’s TA Score shows that 5 TA indicator(s) are bullish while SQZB’s TA Score has 4 bullish TA indicator(s).

  • MIST’s TA Score: 5 bullish, 5 bearish.
  • SQZB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both MIST and SQZB are a good buy in the short-term.

Price Growth

MIST (@Biotechnology) experienced а 0.00% price change this week, while SQZB (@Biotechnology) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

MIST is expected to report earnings on Apr 01, 2025.

SQZB is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIST($95.2M) has a higher market cap than SQZB($737K). SQZB YTD gains are higher at: 25.628 vs. MIST (7.784).
MISTSQZBMIST / SQZB
Capitalization95.2M737K12,917%
EBITDA-39.14MN/A-
Gain YTD7.78425.62830%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash76.4MN/A-
Total Debt54MN/A-
TECHNICAL ANALYSIS
Technical Analysis
MISTSQZB
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 6 days ago
88%
View a ticker or compare two or three
Ad is loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGNE22.640.56
+2.56%
Neurogene
COF178.652.99
+1.70%
Capital One Financial
MSM76.77-0.25
-0.32%
MSC Industrial Direct Co
MCRI78.28-0.83
-1.05%
Monarch Casino & Resort
CETY0.62-0.01
-2.22%
Clean Energy Technologies

SQZB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SQZB has been loosely correlated with MDGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SQZB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
MDGL - SQZB
33%
Loosely correlated
+5.12%
ARRY - SQZB
33%
Loosely correlated
+5.43%
AXON - SQZB
33%
Poorly correlated
+2.60%
MIST - SQZB
31%
Poorly correlated
+4.96%
ACHL - SQZB
30%
Poorly correlated
+0.11%
More